pLKO.1-MKL1/2 shRNA Citations (4)

Originally described in: Activation and repression of cellular immediate early genes by serum response factor cofactors.
Lee SM, Vasishtha M, Prywes R J Biol Chem. 2010 Jul 16. 285(29):22036-49. PubMed Journal

---

Articles Citing pLKO.1-MKL1/2 shRNA

Articles
Synaptic localisation of SRF coactivators, MKL1 and MKL2, and their role in dendritic spine morphology. Kaneda M, Sakagami H, Hida Y, Ohtsuka T, Satou N, Ishibashi Y, Fukuchi M, Krysiak A, Ishikawa M, Ihara D, Kalita K, Tabuchi A. Sci Rep. 2018 Jan 15;8(1):727. doi: 10.1038/s41598-017-18905-7. PubMed
SRF-MRTF signaling suppresses brown adipocyte development by modulating TGF-beta/BMP pathway. Liu R, Xiong X, Nam D, Yechoor V, Ma K. Mol Cell Endocrinol. 2020 Jun 27:110920. doi: 10.1016/j.mce.2020.110920. PubMed
Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer. Tello-Lafoz M, Srpan K, Sanchez EE, Hu J, Remsik J, Romin Y, Calo A, Hoen D, Bhanot U, Morris L, Boire A, Hsu KC, Massague J, Huse M, Er EE. Immunity. 2021 May 11;54(5):1037-1054.e7. doi: 10.1016/j.immuni.2021.02.020. Epub 2021 Mar 22. PubMed
MKL/SRF and Bcl6 mutual transcriptional repression safeguards the fate and positioning of neocortical progenitor cells mediated by RhoA. Cossard A, Stam K, Smets A, Jossin Y. Sci Adv. 2023 Nov 17;9(46):eadd0676. doi: 10.1126/sciadv.add0676. Epub 2023 Nov 15. PubMed

If you have published an article using this material, please email us at to have your article added to this page.